Literature DB >> 1730618

Immunoglobulin heavy chain-binding protein binds to misfolded mutant insulin receptors with mutations in the extracellular domain.

D Accili1, T Kadowaki, H Kadowaki, L Mosthaf, A Ullrich, S I Taylor.   

Abstract

Cell-surface proteins are transported through the endoplasmic reticulum and Golgi apparatus en route to the plasma membrane. Previously, we have identified three point mutations in the insulin receptor gene that impair transport of the mutant receptors to the cell surface: Asn15----Lys, His209----Arg, and Phe382----Val. Furthermore, these mutations impair post-translational processing steps that normally occur as the receptors are transported through the endoplasmic reticulum and Golgi apparatus. In this study, we have demonstrated that the unprocessed Arg209 and Val382 mutant proreceptors are bound to the immunoglobulin heavy chain-binding protein (BiP) in the endoplasmic reticulum. This was demonstrated by the fact that monoclonal anti-BiP antibody coimmunoprecipitated the mutant proreceptors. Moreover, when ATP was added to the immunoprecipitates, the mutant proreceptors were released from BiP. In contrast, neither the normal human insulin receptor nor the Lys15 mutant proreceptor was coimmunoprecipitated by anti-BiP antibody. It seems likely that the Lys15 receptor also binds BiP, but that the affinity was too low to resist dissociation during the stringent washing of the immunoprecipitate. In conclusion, these observation are consistent with the hypothesis that binding to BiP explains the impaired transport of mutant receptors through the endoplasmic reticulum and Golgi apparatus to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730618

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites.

Authors:  T M Bradford; M J Gething; R Davey; J J Hopwood; D A Brooks
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

Review 2.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 3.  Insulin resistance due to mutations of the insulin receptor gene: an overview.

Authors:  D Accili; A Cama; F Barbetti; H Kadowaki; T Kadowaki; S I Taylor
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

4.  Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor.

Authors:  T Kitamura; Y Kido; S Nef; J Merenmies; L F Parada; D Accili
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Chemical rescue of deltaF508-CFTR mimics genetic repair in cystic fibrosis bronchial epithelial cells.

Authors:  Om V Singh; Harvey B Pollard; Pamela L Zeitlin
Journal:  Mol Cell Proteomics       Date:  2008-02-19       Impact factor: 5.911

6.  The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

Authors:  Y Yang; S Janich; J A Cohn; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

7.  An extracellular domain of the beta subunit is essential for processing, transport and kinase activity of insulin receptor.

Authors:  T Haruta; T Sawa; Y Takata; T Imamura; Y Takada; H Morioka; G H Yang; M Kobayashi
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

8.  Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor.

Authors:  R Levy-Toledano; L H Caro; D Accili; S I Taylor
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.